AstraZeneca Australia

We push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve this is to put science at the centre of everything we do.

AstraZeneca’s response to the COVID-19 pandemic

AstraZeneca abides by Medicines Australia’s Code of Conduct and the Therapeutic Goods Act which limit the information that can be provided by a pharmaceutical company to the general public on prescription medicines.  The Australian Government is responsible for all rollout and implementation of COVID-19 vaccinations in Australia.  If you are seeking information on COVID-19 or COVID-19 vaccines please visit the Australian government website: https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines

Update to Australia’s COVID-19 vaccination strategy announced 8 April 2021

We respect the decision taken by the Australian Government based on advice from the Australian Technical Advisory Group on Immunisation (ATAGI) to preference an alternative to AstraZeneca’s COVID-19 vaccine in people under the age of 50. https://www.tga.gov.au/media-release/astrazeneca-chadox1-s-covid-19-vaccine

In the updated recommendation from ATAGI we note their view that the risk-versus-benefit assessment for the use of AstraZeneca COVID-19 vaccine may be different for Australia compared to other countries, such as those with widespread transmission.

AstraZeneca remains committed to supporting the rollout of the vaccination strategy in Australia, and confident that our vaccine has an important role in protecting Australians from the virus.

Overall, regulatory agencies have reaffirmed the vaccine offers protection against all severities of COVID-19 and that these benefits continue to outweigh the risks.

Patient safety remains AstraZeneca’s highest priority and we continue to support regulators in Australia and overseas. Tens of millions of people have now received our vaccine across the globe. The extensive body of data from two large clinical datasets and real-world evidence demonstrate its effectiveness, reaffirming the role the vaccine can play during this public health crisis. Our global commitment remains to play an important role in addressing the current global health emergency posed by COVID-19 by providing a safe and effective vaccine, at no profit during the pandemic.

For Medical Information enquiries or to report an adverse event or product quality complaint about COVID-19 Vaccine AstraZeneca: Visit https://contactazmedical.astrazeneca.com or call the Vaccine Support Line 1800 343 949.

Please contact your doctor or healthcare professional for advice on medicines or any health-related matter as AstraZeneca is unable to provide medical advice to consumers.

AU-10443; Prepared April 2021

  • Who we are

    AstraZeneca Australia is part of the global science-led biopharmaceutical company, AstraZeneca. We are engaged in the research, development, manufacture and supply of medicines that aim to make a real difference to the lives of Australians.

  • What we do

    We focus on three main therapeutic areas; Oncology; Respiratory, Inflammation and Autoimmunity (RIA); Cardiovascular and Metabolic Diseases (CVMD). We build our own capabilities by collaborating with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. At AstraZeneca Australia, we have been working to deliver the best value to patients for more than 50 years, and our vision is to make the most meaningful difference to the lives of Australian patients ensuring Australians have access to our innovative medicines. We are also active in the Infection, Neuroscience and Gastrointestinal (ING) disease areas.

  • Our purpose and values

    Our purpose and values help explain why we exist, what we hope to accomplish, the behaviours we value, how we will achieve our goals, and the promise of our brand to our stakeholders.

Our business strategy

We are focused on returning to growth through science-led innovation

  • Achieve scientific leadership

    We are focusing our science on our main therapy areas and accelerating our pipeline. We are also transforming our way of working.

    Read More

  • Return to growth

    We are focusing on our growth platforms and transforming the business through specialty care, devices and biologics. Targeted business development reinforces our efforts.

    Read more

  • Be a great place to work

    We are evolving our culture and simplifying our business. We want to attract and retain the best talent.

    Read more